Randomized phase 2 study to assess the safety and efficacy of CRLX101 in combination with bevacizumab in patients (pts.) with metastatic renal cell carcinoma (RCC) versus standard of care (SOC) Meeting Abstract

  

Authors:	Voss, M. H.; Coates, A.; Garmey, E. G.; Haas, N. B.; Hutson, T.; Keefe, S. M.; Motzer, R.; Piscitelli, A.; Vogelzang, N. J.; Figlin, R. A.
Abstract Title:	Randomized phase 2 study to assess the safety and efficacy of CRLX101 in combination with bevacizumab in patients (pts.) with metastatic renal cell carcinoma (RCC) versus standard of care (SOC)
Meeting Title:	51st Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title:	Journal of Clinical Oncology
Volume:	33
Issue:	15 Suppl.
Meeting Dates:	2015 May 29-Jun 2
Meeting Location:	Chicago, IL
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2015-05-20
Language:	English
ACCESSION:	WOS:000358036904771
PROVIDER:	wos
DOI:	10.1200/JCO.2015.33.15_suppl.tps4579
Notes:	Meeting Abstract: TPS4579 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/80616